• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, January 5, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

New treatment program offers hope for controlling wombat mange

Bioengineer by Bioengineer
July 24, 2019
in Biology
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Scott Carver

New research from the University of Tasmania is offering hope that the deadly mange disease affecting Tasmanian wombats could eventually be brought under control for wild individuals and populations.

Long-term disease control or eradication in wildlife is rare and represents a major challenge to wildlife conservation across the globe.

Control is particularly difficult for pathogens that can be transmitted through the environment, which includes the mite that causes sarcoptic mange in bare-nosed wombats.

In a paper published today in the Journal of Applied Ecology, researchers present a treatment program and lessons learned from it to guide the development of more effective and feasible control of sarcoptic mange disease in wombat populations.

Disease control was attempted during the mange outbreak at Narawntapu National Park in northern Tasmania, where PhD student Alynn Martin showed the disease could be controlled temporarily using a Cydectin treatment, remotely delivered to wombats using flaps over their burrows.

“The logistics of this treatment made long-term disease control extremely challenging,” she said. “After three months of trying to treat each wombat in the population every week, the disease returned, and wombats continued to die. It was very disappointing to see after going to so much effort to save these wombats.”

Rather than giving up, the researchers used their study to identify practical solutions to the problem.

With the help of University of Tasmania ecological modeller Dr Shane Richards, they discovered that a combination of a longer-lasting treatment and improved delivery of the treatment to the wombats would improve capacity to control mange in wombat populations.

“Slight improvements in multiple aspects of disease control can have dramatic impacts on our capacity to control this disease in wombats,” Dr Richards said.

Lead researcher Dr Scott Carver says that they are now researching a longer-lasting treatment for wombats, called Bravecto.

“We have researched the safety and dose, and are currently determining the effectiveness of the new treatment. Our overarching aim is to make the management of this pathogen much more feasible for individual wild wombats and local at-risk populations,” Dr Carver said.

Dr Richards said that field results suggest that the frequency in which wombats change the burrow in which they sleep was an important factor in disease persistence in populations.

The Sarcoptes scabiei mite was introduced to Australia by European settlers and their domestic animals.

###

Media Contact
Duncan Abey
[email protected]

Related Journal Article

http://dx.doi.org/10.1111/1365-2664.13467

Tags: BiologyEcology/EnvironmentParasitology
Share12Tweet8Share2ShareShareShare2

Related Posts

Romosozumab Outperforms PTH Analogs in Fracture Prevention

Romosozumab Outperforms PTH Analogs in Fracture Prevention

January 4, 2026
blank

Ultra-Low-Dose THC: Gender-Specific Impact on Neuroinflammation

January 4, 2026

FBXW7 Modulates M2 Macrophage Polarization in Endometrial Cancer

January 4, 2026

Unraveling Guanling Cattle’s Genetic Ancestry and Adaptation

January 4, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    PTSD, Depression, Anxiety in Childhood Cancer Survivors, Parents

    138 shares
    Share 55 Tweet 35
  • Exploring Audiology Accessibility in Johannesburg, South Africa

    52 shares
    Share 21 Tweet 13
  • SARS-CoV-2 Subvariants Affect Outcomes in Elderly Hip Fractures

    44 shares
    Share 18 Tweet 11
  • AI Regulation: Fintech Cybersecurity and Privacy in EU vs. Qatar

    44 shares
    Share 18 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Optical Matrix Multipliers Power Image Encoders, Generators

Optimizing AAV9 Therapy for SMARD1: Safety and Efficacy

Unveiling Limits in Spontaneous Brillouin Noise

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 71 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.